NCT04731935View on ClinicalTrials.gov

Novel Earpiece for Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

March 18, 2021

Primary Completion Date

May 26, 2021

Study Completion Date

May 26, 2021

Conditions
Opioid-use DisorderOpioid Withdrawal
Interventions
DEVICE

Sparrow Therapy System

Transcutaneous auricular neurostimulation

Trial Locations (1)

78745

Recovery Unplugged, Austin

All Listed Sponsors
lead

Spark Biomedical, Inc.

INDUSTRY

NCT04731935 - Novel Earpiece for Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal | Biotech Hunter | Biotech Hunter